E2F1 and central nervous system cancer: Reports have shown that downregulation of miR-136-5p in human gliomas is significantly associated with a more aggressive and poor prognostic phenotype; conversely, its overexpression promotes apoptosis and modulates sensitivity to cisplatin by targeting AEG-1, Bcl-2, and E2F1 [33–35].